Skip to main content Back to Top
Advertisement

11/13/2019

Meropenem Injection

Products Affected - Description

    • Merrem injection, Pfizer, 1 gram, vial, 10 count, NDC 00310-0321-30
    • Merrem injection, Pfizer, 500 mg, vial, 10 count, NDC 00310-0325-20
    • Meropenem injection, AuroMedics, 500 mg, vial, 10 count, NDC 55150-0207-20
    • Meropenem injection, Pfizer, 1 gram, vial, 25 count, NDC 00409-3506-01
    • Meropenem injection, Pfizer, 500 mg, vial, 25 count, NDC 00409-3505-01
    • Meropenem injection, Sandoz, 1 gram, vial, 10 count, NDC 00781-3098-95
    • Meropenem injection, Sandoz, 1 gram, vial, 25 count, NDC 00781-3098-96
    • Meropenem injection, Sandoz, 500 mg, vial, 10 count, NDC 00781-3000-95
    • Meropenem injection, Sandoz, 500 mg, vial, 25 count, NDC 00781-3000-96

Reason for the Shortage

    • AuroMedics did not provide a reason for the shortage.
    • Pfizer has meropenem injection on shortage due to manufacturing delays.
    • Sagent discontinued meropenem injection.
    • Sanoz did not provide a reason for the shortage.

Available Products

    • Merrem injection, Pfizer, 1 gram, vial, 10 count, NDC 00069-0314-10
    • Merrem injection, Pfizer, 500 mg, vial, 10 count, NDC 00069-0313-10
    • Meropenem injection, Amneal, 1 gram, vial, 10 count, NDC 70121-1453-07
    • Meropenem injection, Amneal, 500 mg, vial, 10 count, NDC 70121-1454-07
    • Meropenem injection, AuroMedics, 1 gram, vial, 10 count, NDC 55150-0208-30
    • Meropenem injection, BBraun, 1 gm/50 mL, premixed bag, 24 count, NDC 00264-3185-11
    • Meropenem injection, BBraun, 500 mg/50 mL, premixed bag, 24 count, NDC 00264-3183-11
    • Meropenem injection, Fresenius Kabi, 1 gram, vial, 10 count, NDC 63323-0508-30
    • Meropenem injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 63323-0507-20
    • Meropenem injection, Pfizer, 1 gram, vial, 10 count, NDC 00409-1390-21
    • Meropenem injection, Pfizer, 500 mg, vial, 10 count, NDC 00409-1391-21

Estimated Resupply Dates

    • AuroMedics has meropenem 500 mg vials on intermittent back order and the company estimates a release date of early-December 2019.
    • Pfizer has Merrem 500 mg vials (NDC 00310-0325-20) and 1 gram vials (NDC 00310-0321-30) on back order and the company estimates a release date of March 2020. Pfizer has generic meropenem 500 mg (NDC 00409-3505-01) and 1 gram vials (NDC 00409-3506-01) on back order and the company estimates a release date of August 2020.
    • Sandoz has all meropenem presentations on back order and the company cannot estimate a release date.

Updated

Updated November 13, 2019 by Rachael Freeman, PharmD, BCPS. Created September 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins